LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

AutoZone’s stock rises after earnings beat analyst estimates

Clyde Edgerton by Clyde Edgerton
December 5, 2023
in Markets
AutoZone’s stock rises after earnings beat analyst estimates
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


You might also like

Trump, stung by Republican losses, stands his ground on affordability

Reaganomics in Jersey: Jack Ciattarelli has a supply-side dream if he’s elected governor this week

Trump's approval holds steady despite unpopular policies, per new NYT poll

AutoZone Inc. shares fell back fractionally as the auto-parts retailer reported a 10% jump in profit, while its sales benefitted from strength in its international business.

AutoZone’s
AZO,
+0.55%
fiscal first-quarter net income rose to $593.46 million, or $32.55 a share, from $539.32 million, or $27.45 a share, in the year-ago quarter.

The company’s latest earnings per share figure of $32.55 a share beat the FactSet consensus estimate of $26.75 a share.

Sales rose 5.1% to $4.19 billion, in line with analyst estimates.

AutoZone’s total store count rose by 25 net new stores for a total of 7,165 in the U.S., Mexico and Brazil.

“Domestic sales results were solid despite tough comparisons from a year ago, while our international business continues to deliver exceptionally strong sales growth,” said Chief Executive Bill Rhodes.

AutoZone’s stock dipped 0.3% on Tuesday. The stock is up by 7.7% in 2023, compared to an 18.6% rise by the S&P 500.



Source link

Share30Tweet19
Previous Post

Making the grade in financial literacy: More states require students to take a personal finance course

Next Post

Eli Lilly’s new obesity drug Zepbound added to major PBM formularies as it hits pharmacy shelves

Clyde Edgerton

Clyde Edgerton

Recommended For You

Trump, stung by Republican losses, stands his ground on affordability
Markets

Trump, stung by Republican losses, stands his ground on affordability

November 6, 2025
Reaganomics in Jersey: Jack Ciattarelli has a supply-side dream if he’s elected governor this week
Markets

Reaganomics in Jersey: Jack Ciattarelli has a supply-side dream if he’s elected governor this week

November 3, 2025
Trump's approval holds steady despite unpopular policies, per new NYT poll
Markets

Trump's approval holds steady despite unpopular policies, per new NYT poll

September 30, 2025
Trump is selling a strong economy. Voters aren’t buying it.
Markets

Trump is selling a strong economy. Voters aren’t buying it.

September 13, 2025
Next Post
Eli Lilly’s new obesity drug Zepbound added to major PBM formularies as it hits pharmacy shelves

Eli Lilly’s new obesity drug Zepbound added to major PBM formularies as it hits pharmacy shelves

Related News

These nuclear energy stock plays could rise as much as 50%, analysts say

These nuclear energy stock plays could rise as much as 50%, analysts say

August 12, 2024
Bitcoin maxis vs. multichains: Two opposing visions of crypto’s future

Bitcoin maxis vs. multichains: Two opposing visions of crypto’s future

December 4, 2023
This ,400 eight-wheeled dump truck from China is the toy every man needs

This $2,400 eight-wheeled dump truck from China is the toy every man needs

July 19, 2025

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?